You are here
BCN Biosciences L.L.C.
UEI: NXFXKJGKWNM8
# of Employees: 4
HUBZone Owned: No
Socially and Economically Disadvantaged: Yes
Woman Owned: Yes
Award Charts
Award Listing
-
BCN057 as a mitigator of Radiation Induced Gastrointestinal Syndrome
Amount: $599,525.00Project Abstract Currently, there is a need for drugs that mitigate acute radiation induced gastrointestinal syndrome (RIGS). Risk of large populations encountering radiation exposure is real and grow ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
A dual acting drug for enhancing radiotherapeutic benefit
Amount: $209,208.00ABSTRACT: This proposal entitled A dual acting drug for enhancing radiotherapeutic benefit is designed to provide proof of concept evidence that the novel compound EWA001 can protect normal lung ti ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
A novel targeted therapy
Amount: $160,735.00DESCRIPTION (provided by applicant): Cancer is the leading cause of mortality in the United States, despite many advances in the current therapies including surgery, radiation and chemotherapy. Theref ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Translational research in a novel anti cancer agent
Amount: $99,510.00DESCRIPTION (provided by applicant): Natural products possess the richest source of molecular diversity in existence. In the case of cancer therapeutics, natural products have yielded a significant nu ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Botanical-derived drug discovery for cancer therapy
Amount: $130,207.00DESCRIPTION (provided by applicant): In a screen for naturally occurring angiogenic inhibitors, we have identified an extract from the plant Livistona chinensis, which has potent anti-angiogenic and a ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health
